Speakers

Klironomos Leonidas

Pharmacist, MSc (Biostatistics), Acting Head, Clinical Trials Dept, National Organization for Medicines, Greece

Klungel Olaf

Professor of Pharmacoepidemiologic Methods, Head of the division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, the Netherlands

Kontogiorgis Christos

Assistant Professor of Hygiene, Department of Medicine, Democritus University of Thrace, Alexandroupolis, ENCePP expert, Greece

Koraki Evangelia

President HACRO (Hellenic Association of CROs), President & CEO Coronis Research SA

Kotsanis Thanassis

Medical Director and Cluster Medical Director Southern Mediterranean and Black Sea in Bayer.

Landgraf Cordula

Communications & Stakeholder Engagement Director

Swiss Clinical Trial Organisation (SCTO), Switzerland

Lehmann Birka

Senior Expert for Drug Regulatory Affairs and Lecturer at the University of Bonn since 1998

Maniatakou Adamantia

Chemistry BSc, PhD, Patient Safety Specialist, Deputy of Patient Safety Head, Global Drug Development, Novartis

Marcus Robin

RN, BSN, Partner & Sr. Consultant, Tiger Lily Pharma Consulting Services

Matsuyama Kotone

Professor, Department of Health Policy and Management, and Vice President of Center for Strategic Research Initiative, Nippon Medical School & IFAPP Ethics Group Chair

Meier Christoph

internist and endocrinologist and Director of the Department of Internal Medicine at the University Hospital Zurich

Melvin Tom

Associate Professor of Medical Device Regulatory Affairs, Trinity College Dublin

Mitchell Derick

CEO, Irish Platform for Patient Organisations, Science & Industry (IPPOSI), Ireland